Haben Sie sich noch nicht registriert? Hier kostenlos Ihr Konto eröffnen.
Passwort vergessen? Wir werden Ihnen einen Zurücksetzen Link senden
4 Mai 2020
PreveCeutical Announces Possible Viral Prevention Program Using CBD Sol-gel
23 Januar 2020
PreveCeutical Retains Patent Legal Team
14 Januar 2020
PreveCeutical Announces Further Updates to the Successful Engineering & Cell-Based Efficacy Screening of its Smart-siRNA Constructs for its Dual Gene Therapy Research Program
8 Januar 2020
PreveCeutical Announces Positive Results Following a Preliminary Safety Evaluation of Sol-Gel Formulations When Applied to Human Nasal Tissue
29 Oktober 2019
PreveCeutical Announces Successful Completion from its Design, Synthesis and Preliminary Evaluation of Novel Designed Peptides Derived from Caribbean Blue Scorpion Venom in a Cell-Based Brain Cancer Model
7 Oktober 2019
PreveCeutical Receives $616,802 AUD Research and Development Tax Incentive Cash Refund